Fortis Healthcare Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹331
- Today's High:
- ₹347.5
- Open Price:
- ₹341.25
- 52W Low:
- ₹244.6535
- 52W High:
- ₹352
- Prev. Close:
- ₹341.2
- Volume:
- 37153
Company Statistics
- Market Cap.:
- ₹252.87 billion
- Book Value:
- 95.929
- Revenue TTM:
- ₹64.67 billion
- Operating Margin TTM:
- 12.38%
- Gross Profit TTM:
- ₹36.20 billion
- Profit Margin:
- 8.94%
- Return on Assets TTM:
- 4.03%
- Return on Equity TTM:
- 8.38%
Company Profile
Fortis Healthcare Limited had its IPO on under the ticker symbol FORTIS.
The company operates in the Healthcare sector and Medical Care Facilities industry. Fortis Healthcare Limited has a staff strength of 13,010 employees.
Stock update
Shares of Fortis Healthcare Limited opened at ₹341.25 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹331 - ₹347.5, and closed at ₹335.3.
This is a -1.73% slip from the previous day's closing price.
A total volume of 37,153 shares were traded at the close of the day’s session.
In the last one week, shares of Fortis Healthcare Limited have increased by +1.41%.
Fortis Healthcare Limited's Key Ratios
Fortis Healthcare Limited has a market cap of ₹252.87 billion, indicating a price to book ratio of 3.1094 and a price to sales ratio of 3.6858.
In the last 12-months Fortis Healthcare Limited’s revenue was ₹64.67 billion with a gross profit of ₹36.20 billion and an EBITDA of ₹10.28 billion. The EBITDA ratio measures Fortis Healthcare Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Fortis Healthcare Limited’s operating margin was 12.38% while its return on assets stood at 4.03% with a return of equity of 8.38%.
In Q2, Fortis Healthcare Limited’s quarterly earnings growth was a negative -8.6% while revenue growth was a positive 11.4%.
Fortis Healthcare Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 43.6701
- PEG
Its diluted EPS in the last 12-months stands at ₹7.67 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Fortis Healthcare Limited’s profitability.
Fortis Healthcare Limited stock is trading at a EV to sales ratio of 3.8318 and a EV to EBITDA ratio of 19.0215. Its price to sales ratio in the trailing 12-months stood at 3.6858.
Fortis Healthcare Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0.3% and a payout ratio of 13.33%.
Balance sheet and cash flow metrics
- Total Assets
- ₹124.34 billion
- Total Liabilities
- ₹14.26 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 13.33%
Fortis Healthcare Limited ended 2024 with ₹124.34 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹124.34 billion while shareholder equity stood at ₹72.42 billion.
Fortis Healthcare Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹14.26 billion in other current liabilities, 7549581000.00 in common stock, ₹64.87 billion in retained earnings and ₹41.41 billion in goodwill. Its cash balance stood at ₹1.41 billion and cash and short-term investments were ₹3.94 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹5.72 billion.
Fortis Healthcare Limited’s total current assets stands at ₹14.06 billion while long-term investments were ₹0 and short-term investments were ₹315.88 million. Its net receivables were ₹5.82 billion compared to accounts payable of ₹7.14 billion and inventory worth ₹1.23 billion.
In 2024, Fortis Healthcare Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Fortis Healthcare Limited paid ₹0.13 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹335.3
- 52-Week High
- ₹352
- 52-Week Low
- ₹244.6535
- Analyst Target Price
- ₹
Fortis Healthcare Limited stock is currently trading at ₹335.3 per share. It touched a 52-week high of ₹352 and a 52-week low of ₹352. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹329.51 and 200-day moving average was ₹290.27 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 546% of the company’s stock are held by insiders while 7451.1% are held by institutions.
Frequently Asked Questions About Fortis Healthcare Limited
Similar Industry Stocks (Medical Care Facilities)
Most Active
Top Gainers
Top Losers
About
Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Nepal, Sri Lanka, and internationally. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetology/endocrinology, emergency and trauma, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, organ transplanrheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties, as well as ear, nose, and throat. The company was founded in 1995 and is based in Gurugram, India.